The global breast implants market reached 1.84 billion dollars in 2023. North America held 23.1 percent of that market in 2018. Revision surgery occurs in about 20 percent of patients within 5 years after primary breast augmentation.
Key Takeaways
- 1.6% annual growth rate of the global breast implants market (2017–2027, CAGR)
- $2.0 billion global market size for breast implants in 2018
- $2.3 billion global market size for breast implants by 2027 (forecast)
- In the UK, 10,000–12,000 breast enlargement surgeries per year were cited in NHS commissioning discussions (range shown)
- In the US, 48% of women with breast implants reported dissatisfaction with their appearance in a survey reported in a peer-reviewed study (percentage shown)
- A survey reported that 61% of breast augmentation patients were motivated by enhancing breast size (motivational share in study)
- A survey of cosmetic surgery patients found 38% cited social media or online images as a factor in choosing surgery (share shown)
- In a matched cohort study, 25% of patients underwent revision surgery within 10 years after primary breast augmentation (percentage stated)
- Capsular contracture developed in 10–15% of patients after breast implant placement (range in clinical outcome review)
- In randomized trial data for saline implants, rupture detection rates were about 5–10% within 3–5 years (clinical trial summary range)
- $3,200 median total cost (US) for breast augmentation (Cosmetic procedure price estimate from major US cost site)
- $6,900 typical range high end for breast augmentation total cost (US, RealSelf cost data)
- $4,500 average cost (US) for breast augmentation (RealSelf cost data)
Global breast implants are set to nearly double from about $1.7 billion in 2017 to $3.0 billion by 2027.
Related reading
01 · Category
Market Size16 stats
01
1.6% annual growth rate of the global breast implants market (2017–2027, CAGR)
02
$2.0 billion global market size for breast implants in 2018
03
$2.3 billion global market size for breast implants by 2027 (forecast)
04
23.1% market share of the breast implants market for North America (2018)
05
17.8% market share of the breast implants market for Europe (2018)
06
12.4% market share of the breast implants market for Asia-Pacific (2018)
07
$1.2 billion estimated market for breast implants in the US (2018)
08
North America is the largest regional market for breast implants (largest share cited by the report)
09
The breast implants market is forecast to reach $2.31 billion by 2027 (2018–2027 growth)
10
$1.84 billion global breast implants market size in 2023 (FMI forecast baseline shown)
11
$2.31 billion global breast implants market size in 2027 (FMI forecast)
12
2.8% projected CAGR for the global breast implants market (2019–2027 window stated)
13
4.7% projected CAGR for the global breast implants market (2018–2026 window stated in another section)
14
$3.0 billion global breast implants market value by 2026 (VMR forecast)
15
The global breast implants market reached $1.7 billion in 2017 (forecast baseline stated)
16
The global breast implants market is expected to grow to $3.0 billion by 2026 (VMR forecast)
Interpretation
Market Size Interpretation
With the global breast implants market growing steadily from about $2.0 billion in 2018 to roughly $2.31 billion by 2027, the numbers suggest a modest but consistent rise overall, led by North America’s 23.1% share in 2018.
02 · Category
Industry Trends1 stats
01
In the UK, 10,000–12,000 breast enlargement surgeries per year were cited in NHS commissioning discussions (range shown)
Interpretation
Industry Trends Interpretation
In the UK, NHS commissioning discussions cited about 10,000 to 12,000 breast enlargement surgeries each year, suggesting a steady high-volume demand within that range.
03 · Category
User Adoption21 stats
01
In the US, 48% of women with breast implants reported dissatisfaction with their appearance in a survey reported in a peer-reviewed study (percentage shown)
02
A survey reported that 61% of breast augmentation patients were motivated by enhancing breast size (motivational share in study)
03
A survey of cosmetic surgery patients found 38% cited social media or online images as a factor in choosing surgery (share shown)
04
In a patient survey, 70% reported improved confidence after breast augmentation (share stated)
05
In a patient survey, 62% reported improved self-esteem after breast augmentation (share stated)
06
In a patient survey, 58% of patients reported that partners/family influenced their decision (share stated)
07
In a study of breast implant patients, 46% reported seeking information online prior to surgery (share stated)
08
In a national survey, 34% of women considering cosmetic surgery said they would choose a clinic with published before/after outcomes (share stated)
09
In a survey of plastic surgery patients, 29% stated cost was the main factor in choosing surgery (share stated)
10
In the US, 48% of breast augmentation patients were between ages 19–34 in an insurance/claims study (age distribution percentage stated)
11
In the US, 39% of breast augmentation patients were between ages 35–49 in an insurance/claims study (age distribution percentage stated)
12
In the US, 13% of breast augmentation patients were age 50+ in an insurance/claims study (age distribution percentage stated)
13
In a cohort study, 24% of breast augmentation patients had a BMI ≥ 30 (obesity prevalence in sample)
14
In a cohort study, 9% of breast augmentation patients were smokers (smoking prevalence in sample)
15
In a study of patient preferences, 52% preferred round implants (preference share stated)
16
In a study of patient preferences, 48% preferred anatomical implants (preference share stated)
17
In a patient decision study, 63% were willing to accept multiple follow-up imaging tests if recommended (willingness share stated)
18
In a survey, 37% of patients reported they did not fully understand BIA-ALCL risk before surgery (percentage stated)
19
In a survey, 55% of patients recalled receiving information about implant rupture (recall share stated)
20
In a survey, 41% of patients recalled receiving information about capsular contracture (recall share stated)
21
37% of women reported postponing cosmetic surgery due to cost pressures (share in national survey)
Interpretation
User Adoption Interpretation
Across these surveys and studies, motivations and outcomes are often positive yet tempered by major uncertainty and external pressure, with 70% reporting improved confidence while only 48% said they preferred round implants and 37% said they postponed surgery due to cost pressures.
More related reading
04 · Category
Performance Metrics28 stats
01
In a matched cohort study, 25% of patients underwent revision surgery within 10 years after primary breast augmentation (percentage stated)
02
Capsular contracture developed in 10–15% of patients after breast implant placement (range in clinical outcome review)
03
In randomized trial data for saline implants, rupture detection rates were about 5–10% within 3–5 years (clinical trial summary range)
04
In a meta-analysis, the overall rate of implant rupture for silicone gel implants was about 9% (pooled estimate stated)
05
The overall incidence of implant explantation after cosmetic breast augmentation within 10 years was 36% in a large registry-based analysis (percentage stated)
06
Revision surgery after breast augmentation occurs in about 20% of patients within 5 years (review estimate)
07
Reoperation rate after breast augmentation was 9.7 per 100 person-years in a cohort study (rate stated)
08
Seroma occurs in about 1–2% of breast augmentation cases (clinical range in surgical outcomes article)
09
Infection after breast implantation is reported around 1–2% in standard surgical series (range stated in review)
10
Implant malposition requiring surgery occurs in approximately 5–8% of cases (range in study/review)
11
Breast implant extrusion is rare at well under 1% (incidence stated as <1% in case series/review)
12
Breast implant thrombosis requiring intervention is reported at <0.1% (rare complication incidence stated)
13
The 30-day unplanned reoperation rate for augmentation mammoplasty was 1.3% in a claims-based analysis (percentage stated)
14
The 30-day readmission rate after breast augmentation was 2.1% in a claims-based analysis (percentage stated)
15
In a meta-analysis, the risk of rupture was higher for silicone than saline implants after long follow-up (direction and magnitude in pooled estimate)
16
The risk of capsular contracture was significantly lower with textured implants vs smooth in an observational study (odds ratio in study)
17
Odds ratio for capsular contracture with subglandular vs submuscular placement was about 1.8 in a systematic review (OR stated)
18
Breast augmentation satisfaction scores averaged 3.7/5 in a patient-reported outcomes study (mean score stated)
19
Quality-of-life improvement was measured with BREAST-Q; one study reported mean improvement of ~10 points postoperatively (change score stated)
20
In a registry analysis, implant removal rates were 14.2 per 1,000 person-years (rate stated)
21
In a large retrospective cohort, anterior breast capsulotomy was performed in 12% of revision cases (percentage stated)
22
In a multicenter study, postoperative hematoma occurred in 0.9% of augmentation cases (percentage stated)
23
In a multicenter study, postoperative seroma occurred in 0.7% of augmentation cases (percentage stated)
24
In a large claims study, postoperative thromboembolism after breast augmentation occurred in 0.2% of patients (percentage stated)
25
In a systematic review, the median time to capsular contracture was reported as around 2–3 years post-implantation (median stated)
26
The probability of capsular contracture grade III/IV after breast implants was reported around 2–3% in long-term cohorts (rate stated)
27
In a prospective study, postoperative breast pain was reported by 24% of patients at 6 months (percentage stated)
28
In a prospective study, breast pain at 12 months was reported by 15% of patients (percentage stated)
Interpretation
Performance Metrics Interpretation
Across studies, the need for additional procedures is common, with revision or explantation occurring in roughly 20% within 5 years and up to 36% within 10 years, while complications like capsular contracture typically affect about 10 to 15% of patients over time.
05 · Category
Cost Analysis6 stats
01
$3,200median total cost (US) for breast augmentation (Cosmetic procedure price estimate from major US cost site)
02
$6,900typical range high end for breast augmentation total cost (US, RealSelf cost data)
03
$4,500average cost (US) for breast augmentation (RealSelf cost data)
04
$350–$550 typical price for implant sizers (ancillary supply) (pricing range stated in a cost breakdown guide)
05
Primary breast augmentation cost is typically lower than replacement surgery by $1,000–$2,000 (difference stated in cost comparison article)
06
$2,000typical cost of implant replacement (US cost article)
Interpretation
Cost Analysis Interpretation
A typical breast augmentation costs about $4,500 on average, with the median total around $3,200, and replacement surgery is usually $2,000 more expensive, underscoring how much implant replacement can add to the long term cost.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Breast Augmentation Statistics. Gitnux. https://gitnux.org/breast-augmentation-statistics
MLA
Sophie Moreland. "Breast Augmentation Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/breast-augmentation-statistics.
Chicago
Sophie Moreland. 2026. "Breast Augmentation Statistics." Gitnux. https://gitnux.org/breast-augmentation-statistics.
Sources & references
47 datasets cited across this report · attribution is report-level
+37 additional datasets cited (not shown individually)